000 | 01200 a2200349 4500 | ||
---|---|---|---|
005 | 20250514011205.0 | ||
264 | 0 | _c20011205 | |
008 | 200112s 0 0 eng d | ||
022 | _a1351-0088 | ||
024 | 7 |
_a10.1677/erc.0.0080219 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLyons, J F | |
245 | 0 | 0 |
_aDiscovery of a novel Raf kinase inhibitor. _h[electronic resource] |
260 |
_bEndocrine-related cancer _cSep 2001 |
||
300 |
_a219-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aMAP Kinase Kinase Kinase 1 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNeoplasms _xenzymology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-raf _xantagonists & inhibitors |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aWilhelm, S | |
700 | 1 | _aHibner, B | |
700 | 1 | _aBollag, G | |
773 | 0 |
_tEndocrine-related cancer _gvol. 8 _gno. 3 _gp. 219-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1677/erc.0.0080219 _zAvailable from publisher's website |
999 |
_c11488601 _d11488601 |